Patent · US Active

MCAM modulation and uses thereof

US8293468B2 · kind B2 · utility

10Cited by
3References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 9, 2010
Grant dateOct 23, 2012
Priority date
Expiry dateOct 7, 2030

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/285
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Methods, uses, agents and compositions useful for the diagnosis, prevention and/or treatment of inflammatory conditions, such as neuroinflammatory conditions such as multiple sclerosis, and for the identification and selection of inflammatory cytokine-secreting T cell or a precursor thereof, based on the expression and/or modulation of melanoma cell adhesion molecule (MCAM) are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.